BIOMEA FUSION INC. - COMMON STOCK
8.0250
12-November-24 13:44:00
15 minutes delayed
Stocks
-0.0050
-0.06%
Today's range
7.9100 - 8.1800
ISIN
N/A
Source
NASDAQ
-
Biomea Fusion Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
28 Feb 2022 15:05:01 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces Appointment of Steve Morris, M.D. as Chief Medical Officer
01 Feb 2022 05:30:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces First Patient Dosed
25 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Announces Participation at the H.C. Wainwright 2022 BioConnect Conference
11 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
10 Jan 2022 07:30:01 By Nasdaq GlobeNewswire
-
Biomea Fusion Releases Pre-Clinical Data with BMF-219 in Diabetes
06 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Moves into New Headquarters and Expands R&D Facility
04 Jan 2022 12:30:14 By Nasdaq GlobeNewswire
-
Biomea Fusion to Present at the 40th Annual J.P. Morgan Healthcare Conference
21 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
Biomea Fusion to be added to NASDAQ Biotechnology Index
14 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
Biomea Fusion to Participate in Two Upcoming Investor Conferences
10 Nov 2021 13:00:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Publishes Abstract on BMF-219 at ASH Annual Meeting
04 Nov 2021 09:49:38 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports Third Quarter 2021 Financial Results and Business Highlights
03 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
16 Sep 2021 12:35:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports Second Quarter 2021 Financial Results and Business Highlights
11 Aug 2021 15:05:01 By Nasdaq GlobeNewswire
-
28 Jun 2021 18:10:00 By Nasdaq GlobeNewswire
-
Biomea Fusion Reports First Quarter 2021 Financial Results and Business Highlights
27 May 2021 15:05:00 By Nasdaq GlobeNewswire
-
Biomea Announces Closing of Initial Public Offering
20 Apr 2021 15:05:00 By Nasdaq GlobeNewswire